Introduction
The oral cavity is one of the most complex microbial ecosystems present in humans, and the human oral microbiome comprises more than 700 bacterial species (1, 2) . Dental caries and periodontal disease are common oral conditions caused by bacterial infection and the formation of dental plaque (3, 4) . Dental caries results from acid demineralization of the tooth enamel by oral microorganisms (5, 6) , whereas periodontal disease is most commonly a chronic bacterial infection with detrimental effects on the gums and bone supporting the teeth. These conditions evolve episodically, with phases of active destruction, latency and healing (7) .
The control of infectious diseases caused by bacteria has been transformed since the discovery of antibacterial drugs (8) . A variety of antimicrobial agents, including fluorides, phenol derivatives, ampicillin, erythromycin, penicillin, tetracycline, and vancomycin have been used widely in dentistry for inhibiting the proliferation of bacteria (9) (10) (11) . However, excessive use of these agents can cause side effects such as susceptibility to microorganisms, vomiting, diarrhea and tooth staining, as well as disturbance of the oral and intestinal environment (10, (12) (13) . Therefore there is a need to search for new natural antimicrobial agents that are safe and act specifically against human oral pathogens. Plants have a largewhich have been reported to have antimicrobial properties (14) (15) (16) .
Sophorae Radix, the dried root of Sophora flavescens (S. flavescens) AITON (Leguminosae), has traditionally been used as an important herbal medicine in Korea. It is known to be effective for a variety of diseases, exerting antipyretic, analgesic, antihelminthic, antibacterial, anti-inflammatory, antioxidant, and antimalarial effects (17) (18) (19) . The root of S. flavescens includes alkaloids, triterpenoids, and flavonoids, and exerts anti-inflammatory, antioxidant, antimicrobial, and anti-diabetic effects (17, (19) (20) (21) (22) (23) . Some of the prenylated flavonoids isolated from S. flavescens root, including sophoraflavanone G, kuraridin, and kurarinone, have been shown to inhibit eicosanoid-producing enzymes such as cyclooxygenase-1 (COX-1), COX-2, 5-lipoxygenase (5-LOX), and 12-LOX (24, 25) . We previously reported that sophoraflavanone G isolated from S. flavescens root exerts antibacterial effects against oral bacteria (26) .
In the present study, we investigated the antibacterial activities of the extract and several fractions of S. flavescens root against oral pathogens, including cariogenic and periogenic bacteria.
Materials and Methods
Plant material and preparation of S. flavescens root extract and fractions S. flavescens was purchased from the herbal medicine cooperative association of Jeonbuk Province, Korea, in March 2005. The dried and powered roots of S. flavescens were extracted by repeated refluxing with methanol (MeOH) for 4 h at 80°C, and the MeOH extract was then filtered and evaporated to a thick syrup. The MeOH extract was suspended in water (H 2 O) and partitioned with the same volume of chloroform (CHCl 3 ), hexanol (HEX), ethyl acetate (EtOAc), and n-butanol (n-BuOH) three successive times. The organic solvent extracts were evaporated in vacuum at 45°C to yield CHCl 3 , HEX, EtOAc, and n-BuOH soluble fractions. The extracts and fractions were then dissolved in 10% dimethyl sulfoxide (DMSO, Sigma Chemical Co., St. Louis, MO, USA) for testing. All of the extracts and fractions were kept at 4°C in the dark until further use.
Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs)
The oral bacterial strains used in this study were: The minimum inhibitory concentrations (MICs) were determined by using the micro-dilution method as previously described (26) . MIC was determined as the lowest concentration of a test sample that completely inhibited any visible growth in the broth. MIC 50 and MIC 90 , defined as the MIC at which 50% and 90% of oral bacteria were inhibited, respectively, were determined. One hundred microliters from the invisible growth were inoculated in triplicate on BHI agar and incubated at 37°C for 24 h; MBC was defined as the lowest concentration of n-BuOH or EtOAc fractions of S. flavescens root that inhibited growth on BHI agar. The lowest concentration of sample that could kill 99.9% of bacteria was determined as the MBC. Ampicillin, gentamicin, erythromycin, and vancomycin were used as standard antibiotics for comparing the sensitivity of the extract and several fractions of S. flavescens root.
Checkerboard dilution test
The effects of the n-BuOH or EtOAc fractions of S. flavescens root in combination with antibiotics were assessed using a checkerboard dilution test (26) . Serial dilutions of two different antimicrobial agents were mixed in broth medium for various times. After 24 h of incubation at 37°C, the MIC and MBC were determined as the minimal concentration at which there was no visible growth and 99.9% of the test bacteria were killed, respectively. 
Time-kill assay
Time-kill curve determination of antibacterial and synergistic activities against oral bacteria was performed using the broth macrodilution method (26) . The following samples were incubated in Mueller Hinton Broth (MHB, Becton, Dickinson and Company, Sparks, MD, USA) at 37°C under anaerobic conditions: oral bacteria 5-7×10 6 CFU/mL + n-BuOH fraction (MIC); oral bacteria 5-7×10 6 CFU/mL + n-BuOH fraction (1/2 MIC) + Amp (1/2 MIC); and oral bacteria 5-7×10 6 CFU/mL + n-BuOH fraction (1/2 MIC) + Gen (1/2 MIC). After incubation for 0 and 30 min, and 1, 2, 3, 4, 5, 6, 12, and 24 h, 100-µL bacterial aliquots were taken and spread onto BHI agar for counting of colony-forming units (CFUs).
Statistical analysis
All experiments were carried out in triplicate. The data were expressed as mean ± standard error of the mean (SEM). One-way ANOVA using SPSS ver. 19.0 software (SPSS Inc., Chicago, IL, USA) was performed for multiple comparisons. Differences at P < 0.05 were considered statistically significant.
Results

Minimum inhibitory concentrations/minimum bactericidal concentrations of extract and several fractions of S. flavescens root and antibiotics
The antibacterial and combination effects of extracts and several fractions of S. flavescens roots, or those of antibiotics, were determined. The MIC/MBC for the MeOH extract ranged from 2.5 to 20 μg/mL and from 5 to 40 μg/ mL; for the CHCl 3 fraction the values ranged from 0.625 to 5 μg/mL and from 1.25 to 10 μg/mL; for the n-BuOH fraction the values ranged from 0.313 to 2.5 μg/mL and from 0.625 to 5 μg/mL; for the HEX fraction the values ranged from 1.25 to 5 μg/mL and from 2.5 to 10 μg/mL; and for the EtOAc fraction the values ranged from 0.625 to 5 μg/mL and from 1.25 to 10 μg/mL, respectively ( Table 1 ). The MIC 50 and MIC 90 determinations for all of the tested bacteria confirmed a high antibacterial activity of the extract and several fractions of S. flavescens root. The MIC 50 and MIC 90 ranges for the MeOH extract were 0.625-5 μg/mL and 2.5-20 μg/mL; those for the CHCl 3 fraction were 0.156-1.25 μg/mL and 0.313-5 μg/mL; those for the n-BuOH fraction were 0.156-0.625 μg/mL and 0.313-2.5 μg/mL; those for the HEX fraction were 0.313-2.5 μg/mL and 1.25-5 μg/mL; and those for the EtOAc fraction were 0.156-1.25 μg/mL and 0.625-5 μg/ mL, respectively ( Table 2 ). The n-BuOH fraction exhibited markedly stronger activity than the other fractions and extracts against S. mutans, S. sobrinus, S. anginosus, S. gordonii, F. nucleatum, P. intermedia, and P. gingivalis, and the EtOAc fraction was stronger active against S. mutans, P. intermedia, and P. gingivalis. Determination of antimicrobial activity showed that ampicillin exerted antimicrobial activity against cariogenic bacteria (MIC, 0.5-2 µg/mL; MBC, 1-4 µg/mL) and against periogenic bacteria (MIC, 0.25-8 µg/mL; MBC, 0.25-16 µg/mL). The corresponding values for gentamicin were 2-16/4-32 and 2-256/4-512 μg/mL, those for erythromycin were 0.008-0.125/0.016-0.5 and 0.125-32/0.25-64 μg/mL, and those for vancomycin were 0.25-1/0.5-4 and 2-64/4-128 μg/mL on all the tested bacteria (Table 1) .
Synergistic effect of n-BuOH and EtOAc fractions of S. flavescens root with antibiotics
The antibacterial activities of the n-BuOH and EtOAc fractions alone and in combination with antibiotics (Amp or Gen) against oral bacteria are presented in Tables 
Time killing by the n-BuOH fraction of S. flavescens root with antibiotics
The antibacterial effect of the n-BuOH fraction of S. flavescens with Amp or Gen against oral bacteria was confirmed by time-kill curve experiments. The n-BuOH fraction alone (MIC or 2× MIC) resulted in an increased rate of killing in terms of CFU/mL in a time-dependent manner, and showed a more rapid rate of killing when combined with 1/2 MIC of Amp or Gen (Figs. 1, 2 ).
Discussion
The main etiologic factors of dental caries and periodontal disease are dental plaque and biofilm (3, 6) . Therefore, natural products with antiplaque properties, antimicrobial activity, and inhibitory effects against biofilm formation by oral pathogens would be desirable Antibiotics such as ampicillin, chlorhexidine, erythromycin, penicillin, tetracycline, and vancomycin have been used to prevent and treat dental caries (12, 16, 30) . Recently, some plant extracts have been shown to have superior efficacy against antibiotic-resistant bacteria (31) . A number of recent studies have investigated the antimicrobial activity of a number of plant extracts and natural materials against oral bacteria (8, 32, 33) . Some flavonoid derivatives of S. flavescens, such as quercetin, sophoraflavanone G, and kaempferol, have already been shown to have antimicrobial and antimalarial activities (21, 26, 34) . The antimicrobial activity is related more to the synergistic effect of several flavonoids rather than the effect of any specific compound alone (21, 26, 33) . Phytoalexins isolated from Sophora exigua (Leguminosae) have been investigated for their their growth-inhibitory effects on oral cariogenic bacteria (35) . In the present study, a synergistic effect was obtained with the n-BuOH fraction plus Amp against the oral bacteria we tested with a FICI of ≤0.5/0.5, except for F. nucleatum in terms of MIC (FICI of ≤0.75), and with the n-BuOH fraction plus Gen against S. mutans, S. sanguinis, S. sobrinus, S. criceti, S. gordonii, A. actinomycetemcomitans, F. nucleatum, and P. gingivalis with a FICI of ≤0.5. In combination with the EtOAc fraction, the MIC for Amp was reduced ≥4-fold in the tested bacteria, producing a synergistic effect as defined by FICI ≤ 0.5, except for F. nucleatum (FICI ≤ 0.75), and with Gen against oral bacteria was 0.5 for MIC, except for S. sobrinus, S. anginosus, and P. intermedia. The chemical structures of the alkaloid-free prenylated flavonoid-enriched fraction were identified as sophoraflavanone G, kuraridin, and kurarinone (17, 35, 36) . Antimicrobial activity of flavonoid complexes is achieved by attachment to extracellular soluble proteins and bacterial cell walls (37, 38) . Therefore these agents may have significant clinical value for treatment of drugresistant microbial strains. In this study, S. flavescens root extract and fractions that contain many flavonoids showed high antibacterial activity. The synergistic effect of the n-BuOH fraction of S. flavescens with Amp or Gen against oral bacteria was confirmed. Combination of the n-BuOH fraction of S. flavescens with Amp or Gen achieved a rapid rate of killing against most of the tested bacteria. The n-BuOH fraction of S. flavescens with Amp or Gen was able to kill 100% of most tested bacteria within 1-6 h.
In conclusion, the present results show that S. flavescens root extract and fractions exhibit selective antibacterial activities against S. anginosus and S. gordonii. These findings suggest that S. flavescens root extract satisfies the conditions required for a novel antibacterial agent against cariogenic and periogenic pathogens, and may be useful for future prevention and treatment of diseases caused by oral bacteria.
